H. Res. 586, Resolution Expressing Support for a Guaranteed Buyer of Vaccines and a Marshall Plan
Summary
H. Res. 586, a resolution submitted in the House of Representatives on August 13, 2021 by Mr. Auchincloss and other members and referred to the Committee on Foreign Affairs. It expresses support for the United States Government to be a guaranteed buyer of vaccines and for the United States to develop a ‘‘Marshall Plan’’ for global vaccinations. The preamble refers to $11.5 billion in the American Rescue Plan for a global COVID–19 response and to COVAX. Among the resolved clauses, the House encourages direct and comprehensive investment in the vaccine supply chain at a level sufficient to meet global needs by mid-2022.
Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used
- Issuer
- Congressional materials
- Document type
- Bills Bills 117Hres586Ih Bills 117Hres586Ih
- Case
- Bills Bills 117Hres586Ih Bills 117Hres586Ih
Cite this document
“H. Res. 586, Resolution Expressing Support for a Guaranteed Buyer of Vaccines and a Marshall Plan.”
Original at www.govinfo.gov. Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/bills-bills-117hres586ih-bills-117hres586ih/
, SHA-256 44040a1c8330435f4097165a15b798c9689e3d5ca52fc2697738e1b44760b890.Full text
IV
117TH CONGRESS
1ST SESSION
H. RES. 586
Expressing support for the United States Government to be a guaranteed
buyer of vaccines and for the United States to develop a ‘‘Marshall
Plan’’ for global vaccinations.
IN THE HOUSE OF REPRESENTATIVES
AUGUST 13, 2021
Mr. AUCHINCLOSS (for himself, Mr. KRISHNAMOORTHI, Mr. PETERS, Mr.
ESPAILLAT, Mr. POCAN, Mr. LARSON of Connecticut, Mr. NEGUSE, Mr.
MCGOVERN, Ms. ROSS, Ms. JAYAPAL, Mr. KHANNA, Ms. STRICKLAND,
Ms. JACOBS of California, Mr. KAHELE, Mr. WELCH, Mr. GARCÍA of Illi-
nois, Ms. TITUS, Ms. NORTON, Ms. CHU, Mr. TAKANO, Mr. BOWMAN,
and Ms. WILLIAMS of Georgia) submitted the following resolution; which
was referred to the Committee on Foreign Affairs
RESOLUTION
Expressing support for the United States Government to
be a guaranteed buyer of vaccines and for the United
States to develop a ‘‘Marshall Plan’’ for global vaccina-
tions.
Whereas, as the United States recovery from COVID–19 ac-
celerates, the United States has an opportunity and a re-
sponsibility to provide global leadership in both vaccine
procurement and delivery in the battle against the pan-
demic;
lotter on DSK11XQN23PROD with BILLS
Whereas the American Rescue Plan provided $11.5 billion to
support a global COVID–19 response, including $750
VerDate Sep 11 2014 20:22 Aug 13, 2021 Jkt 019200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6300 E:\BILLS\HR586.IH HR586
2
million for global health activities to aid our global part-
ners with health security, disease detection and response,
and immunization;
Whereas the Biden administration has committed to donating
millions of vaccines to partners across the world and
pledged to work with COVID–19 Vaccines Global Access,
or COVAX, and other partners to ensure these doses are
delivered fairly;
Whereas United States diplomatic leadership led to the com-
mitment of an additional 870 million doses of COVID–
19 vaccines at the G7 summit, to ensure fair global ac-
cess and pave the way to global recovery to address the
secondary impacts of the pandemic including routine
health service disruption, interrupted education, and ex-
acerbated inequalities;
Whereas expanding vaccine production and assuring safe and
widespread distribution will give the United States great-
er leverage in vaccine diplomacy and act as a counter-
weight to the role being sought by China and Russia;
Whereas just as the Marshall Plan aided in Europe’s recovery
from the devastation of World War II, the commitment
of United States vaccine resources can save countless
lives and contribute to the recovery of global economies
by leading a global vaccination initiative to beat back the
pandemic and build response capacity for the future;
Whereas a global population of over 7 billion people, many
in low- and middle-income nations, and the likelihood of
each of these 7 billion needing 2 to 4 doses of vaccine,
both initially and as booster shots, will require the pro-
lotter on DSK11XQN23PROD with BILLS
duction of more than 12 billion doses immediately;
•HRES 586 IH
VerDate Sep 11 2014 19:45 Aug 13, 2021 Jkt 019200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6300 E:\BILLS\HR586.IH HR586
3
Whereas administering vaccines safely and efficiently using
multidose vials and separate syringes in nations with lim-
ited medical infrastructure and isolated populations pre-
sents significant logistical challenges;
Whereas these delays can, and have already, led to the emer-
gence of more dangerous and highly contagious variants
of the disease;
Whereas these immunizations cannot be administered without
health care workers, all of whom must be prioritized in
order to ensure those who are ill have medical profes-
sionals who are healthy and able to provide the necessary
care;
Whereas the United States should increase direct investments
in the full vaccine manufacturing supply chain through
public-private partnerships that will create jobs, leverage
vaccine diplomacy, support the biomanufacturing indus-
try, and enable the world to be better prepared for future
pandemics;
Whereas investment in the full supply chain, including fill
and finish capacity, will allow the United States also to
lead in addressing a major cause of health care-associ-
ated injury and death; and
Whereas the United States has a responsibility to lead the
world in COVID–19 immunization: Now, therefore, be it
1 Resolved, That the House of Representatives—
2 (1) affirms the United States enduring commit-
3 ment to international partnerships that protect the
4 health of all persons;
lotter on DSK11XQN23PROD with BILLS
5 (2) supports COVID–19 Vaccines Global Access
6 and its mission to accelerate the development and
•HRES 586 IH
VerDate Sep 11 2014 19:45 Aug 13, 2021 Jkt 019200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\HR586.IH HR586
4
1 manufacturing of COVID–19 vaccines to guarantee
2 fair and equitable access;
3 (3) emphasizes the need to distribute vaccines
4 globally based on epidemiological and need-based
5 formulas where infection rates are highest;
6 (4) understands the importance of Advanced
7 Market Commitments to ensure sufficient supply of
8 end-product vaccines and component raw materials;
9 and
10 (5) encourages direct and comprehensive invest-
11 ment in the vaccine supply chain akin to the ‘‘Mar-
12 shall Plan’’ of post-World War II recovery at a level
13 sufficient to meet global needs by mid-2022.
Æ
lotter on DSK11XQN23PROD with BILLS •HRES 586 IH
VerDate Sep 11 2014 19:45 Aug 13, 2021 Jkt 019200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6301 E:\BILLS\HR586.IH HR586
File and source
- File
- BILLS_bills-117hres586ih_bills-117hres586ih.pdf
- Size
- 234,256 bytes
- SHA-256
- 44040a1c8330435f4097165a15b798c9689e3d5ca52fc2697738e1b44760b890
- Original
- www.govinfo.gov